China NT Pharma Group Company Limited

SEHK:2965 Rapporto sulle azioni

Cap. di mercato: HK$68.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

China NT Pharma Group Gestione

Gestione criteri di controllo 3/4

China NT Pharma Group's CEO is David Ng, appointed in Jan 1995, has a tenure of 29.58 years. total yearly compensation is CN¥1.67M, comprised of 99% salary and 1% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$6.50K. The average tenure of the management team and the board of directors is 2.7 years and 7.2 years respectively.

Informazioni chiave

David Ng

Amministratore delegato

CN¥1.7m

Compenso totale

Percentuale dello stipendio del CEO99.0%
Mandato del CEO29.6yrs
Proprietà del CEO0.009%
Durata media del management2.7yrs
Durata media del Consiglio di amministrazione7.2yrs

Aggiornamenti recenti sulla gestione

Nessun aggiornamento

Recent updates

Nessun aggiornamento

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di David Ng rispetto agli utili di China NT Pharma Group?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023CN¥2mCN¥2m

-CN¥33m

Jun 30 2023n/an/a

-CN¥44m

Mar 31 2023n/an/a

-CN¥55m

Dec 31 2022CN¥2mCN¥2m

-CN¥50m

Sep 30 2022n/an/a

-CN¥121m

Jun 30 2022n/an/a

-CN¥175m

Mar 31 2022n/an/a

-CN¥162m

Dec 31 2021CN¥2mCN¥1m

-CN¥150m

Sep 30 2021n/an/a

-CN¥147m

Jun 30 2021n/an/a

-CN¥145m

Mar 31 2021n/an/a

-CN¥167m

Dec 31 2020CN¥2mCN¥2m

-CN¥189m

Sep 30 2020n/an/a

-CN¥271m

Jun 30 2020n/an/a

-CN¥353m

Mar 31 2020n/an/a

-CN¥351m

Dec 31 2019CN¥6mCN¥6m

-CN¥350m

Sep 30 2019n/an/a

-CN¥547m

Jun 30 2019n/an/a

-CN¥744m

Mar 31 2019n/an/a

-CN¥670m

Dec 31 2018CN¥9mCN¥6m

-CN¥596m

Sep 30 2018n/an/a

-CN¥190m

Jun 30 2018n/an/a

CN¥216m

Mar 31 2018n/an/a

CN¥215m

Dec 31 2017CN¥8mCN¥6m

CN¥214m

Compensazione vs Mercato: David's total compensation ($USD232.93K) is about average for companies of similar size in the Hong Kong market ($USD235.36K).

Compensazione vs guadagni: David's compensation has increased whilst the company is unprofitable.

AMMINISTRATORE DELEGATO

David Ng (60 yo)

29.6yrs

Mandato

CN¥1,669,000

Compensazione

Mr. Tit Ng, also known as David, has been the Chief Executive Officer and Chairman of China NT Pharma Group Company Limited since 1995. He is a Co-Founder of NT Pharma Group Company Limited. Mr. Ng was app...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
CN¥ 6.5k
Jing Fang
Chief Financial Officer4.8yrsNessun datoNessun dato
Ching Mei Ng
Executive Directorless than a yearNessun datoNessun dato
Cheung Cheng
Company Secretaryless than a yearNessun datoNessun dato

2.7yrs

Durata media

44yo

Età media

Gestione esperta: 2965's management team is considered experienced (2.7 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
CN¥ 6.5k
Ching Mei Ng
Executive Directorless than a yearNessun datoNessun dato
Yu Chin
Non-Executive Director14.4yrsCN¥138.00k0.0095%
CN¥ 6.5k
Wei Qian
Non-Executive Director14.4yrsNessun datoNessun dato
Tze Shan Yu
Independent Non-Executive Director7.2yrsCN¥138.00k0.0057%
CN¥ 3.9k
Ming Kwan Ng
Independent Non-Executive Director1.6yrsCN¥138.00kNessun dato
Yubiao Zhao
Independent Non-Executive Director4.7yrsCN¥138.00kNessun dato

7.2yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: 2965's board of directors are considered experienced (7.2 years average tenure).